Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery

Cancer Biology and Therapy

Volumn 11, Issue 7, 2011, Pages 633-638

  Ren, Chuanli ^a   He, Ping ^b   Zhang, Jinqiang ^b   Zheng, Zhaoxu ^b   Qiao, Yuanyuan ^c   Zhao, Xiaohang ^b,c  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c General Navy Hospital   (China)

Author keywords

Circulating tumor cells; Esophageal squamous cell carcinoma; Fluorescence in situ hybridization; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD133 ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8;

AGED; ARTICLE; BLOOD; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CASE REPORT; CELL MEMBRANE; CELL STRUCTURE; CHROMOSOME 20; CHROMOSOME 8; CHROMOSOME ANALYSIS; CIRCULATING TUMOR CELL; CLINICAL FEATURE; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; LUNG METASTASIS; MALE; PHENOTYPE; PRIMARY TUMOR; TUMOR CELL;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 8; ESOPHAGEAL NEOPLASMS; FATAL OUTCOME; GLYCOPROTEINS; HUMANS; KERATINS; MALE; NEOPLASTIC CELLS, CIRCULATING; PEPTIDES;

EID: 79953314667     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.7.14950     Document Type: Article

References (27)

1. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6:339-51.
2. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58-68. (Pubitemid 350309740)
3. Takeuchi H, Kitagawa Y. Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci 2010; 17:577-82.
4. Lam AK. Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 2000; 33:71-90. (Pubitemid 30085471)
5. Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 2007; 13:2992-7. (Pubitemid 46849575)
6. Lurje G, Schiesser M, Claudius A, Schneider PM. Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol 2010; 2010:392652-10.
7. Pantel K, Alix-Panabieres C. The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 2007; 4:62-3. (Pubitemid 46189529)
8. Meng S, Tripathy D, Shete S, Ashfaq R, Saboorian H, Haley B, et al. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proc Natl Acad Sci USA 2006; 103:17361-5. (Pubitemid 44788974)
9. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA 2004; 101:9393-8. (Pubitemid 38812885)
10. Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002; 8:2073-84. (Pubitemid 34753576)
11. Mocellin S, Keilholz U, Rossi CR, Nitti D. Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 2006; 12:130-9.
12. Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, Humphrey M, et al. Case study of the morphologic variation of circulating tumor cells. Hum Pathol 2007; 38:514-9. (Pubitemid 46227530)
13. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: Clinical impact and future directions. Cancer Lett 2007; 253:180-204. (Pubitemid 47017533)
14. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359:1727-33.
15. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008; 8:329-40. (Pubitemid 351596394)
16. Liu Z, Fusi A, Schmittel A, Tinhofer I, Schneider A, Keilholz U. Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. Cancer Biol Ther 2010; 10:1-5.
17. Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, et al. Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010; 2010:861341.
18. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10:6897-904. (Pubitemid 39383039)
19. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med 2004; 351:781-91. (Pubitemid 39095313)
20. Yang Y, Chu J, Wu Y, Luo M, Xu X, Han Y, et al. Chromosome analysis of esophageal squamous cell carcinoma cell line KYSE 410-4 by repetitive multicolor fluorescence in situ hybridization. J Genet Genomics 2008; 35:11-6.
21. Fehm T, Solomayer EF, Meng S, Tucker T, Lane N, Wang J, et al. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 2005; 7:171-85. (Pubitemid 40872753)
22. Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res 2009; 15:2091-7.
23. Marrinucci D, Bethel K, Luttgen M, Bruce RH, Nieva J, Kuhn P. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med 2009; 133:1468-71.
24. Katz RL, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, et al. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 2010; 16:3976-87.
25. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-23. (Pubitemid 47355323)
26. Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D, et al. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 2010; 288:99-106.
27. Fehm T, Morrison L, Saboorian H, Hynan L, Tucker T, Uhr J. Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 2002; 75:227-39. (Pubitemid 35026116)